SuperworthImmucell shares outstanding ICCC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 9.2M
- On a year earlier
- +1.8%
- more shares
Immucell had 9.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 9M | +1% |
| FY2024 | 8.9M | +15% |
| FY2023 | 7.8M | +0% |
| FY2022 | 7.7M | +0% |
| FY2021 | 7.7M | +7% |
| FY2020 | 7.2M | +0% |
| FY2019 | 7.2M | +31% |
| FY2018 | 5.5M | +8% |
| FY2017 | 5.1M | +6% |
| FY2016 | 4.8M | +51% |
| FY2015 | 3.2M | +5% |
| FY2014 | 3M | +0% |
| FY2013 | 3M | +0% |
| FY2012 | 3M | +0% |
| FY2011 | 3M | +2% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 9.2M | +2% | |
| Q1 FY26 | 9M | +1% | |
| Q4 FY25 | 9M | +1% | |
| Q3 FY25 | 9M | +11% | |
| Q2 FY25 | 9M | +16% | |
| Q1 FY25 | 9M | +16% | |
| Q4 FY24 | 8.9M | +15% | |
| Q3 FY24 | 8.2M | +5% | |
| Q2 FY24 | 7.8M | +1% | |
| Q1 FY24 | 7.8M | +0% | |
| Q4 FY23 | 7.8M | +0% | |
| Q3 FY23 | 7.7M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Immucell
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.